Heart and androgens;Cœur et androgènes

Revue Medicale de Liege

Volumn 59, Issue 7-8, 2004, Pages 439-444

  Smeets, L ^a   Legros, J J ^b  

^a Serv Universitaire d'Endocrinologie   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Androgens; Coronary artery disease; Heart failure; Lipidic profile; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPID; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; CYTOKINE RELEASE; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY MECHANISM; REVIEW; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD VESSEL; HEART; PHYSIOLOGY;

ANDROGENS; BLOOD VESSELS; CORONARY DISEASE; HEART; HUMANS;

EID: 4544352629     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Stearns EI, Mac Donnel JA, Kaufman Bj et al. - Declining testicular function with age. Am J Med, 1974, 57, 761-766
2. Gyllenborg J, Susane L, Borch-Johnsen K et al. - Cardiovascular risk factors in men: the role of gonadal steroids and sex hormone binding protein. Metabolism, 2001, 50, 882-888
3. Moriyama Y, Yasue H, Yoshimura M et al. - The plasma levels of DHEAS are decreased in patient with chronic heart failure in proportion to severity. J Clin Endocrinol Metab, 2000, 85, 1834-1840.
4. Silver MD. - Cardiovascular pathology. Deuxième édition. Churchill Livingstone, New York, 1991.
5. Schaible TF, Malhotral A, Ciambrone G et al. - The effect of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res. 1984, 54, 38-49.
6. Malhotra A, Buttrick, Scheuer J et al. - Effects of sex hormones on development of physiological and pathological hypertrophy in male and female rat. Am J physiol. 1990, 25, 866-871
7. Scheuer J, Malhotra A, Schaible TF et al. - Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 1987, 61, 12-19.
8. Melchert RB, Herron TJ, Welder AA. - The effect of anabolic-androgenic steroids on primary myocardial cell cultures. Med Sci Sports Exerc, 1992, 24, 206-212
9. Campbell SE, Farb A, Weber KT. - Pathologic remodelling of the myocardium in a weightlifter taking anabolic steroids. Blood press. 1993, 2, 213-216
10. Marsh JD, Lehmann MH, Ritchie RH et al. - Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 1998, 98, 256-261
11. Morano I, Gerstener J, Ruegg JC, et al. - Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ Res, 1990, 66, 1585-1590.
12. Thum T, Borlak J. - Testosterone, cytochrome P450 and cardiac hypertrophy. FASEB J, 2002, 16, 1537-1549
13. Tappler B, Katz M. - Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol, 1979, 10, 219-226
14. Noirhomme P, Jaquet L, Underwood M et al. - The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure. Eur J Cardiothorac Surg, 1999, 16, 63-67.
15. Seta V, Shan K, Bozkurt B, et al. - Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail, 1996, 2, 243-9.
16. Pugh PJ, English KM, Jones TH et al. - Testosterone: a natural tonic for the failing heart? QJM, 2000, 93, 689-694.
17. Gregory CW, He B, Wilson EM. - The putative androgen receptor-A form results from in vitro proteolysis. J mol Endocrinol 2001, 27, 309-319.
18. Coats A. - Origin of symptoms in patients with cachexia with special references to weakness and shortness. Int J cardiol 2002, 85, 133-139
19. Higashiura K, Mathur RS, Halushka PV. - Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth muscle cells. J cardiovasc pharmacol, 1991, 29, 311-215.
20. Webb CM, Mc Neill JG, Hayward CS et al. - Effect of testosterone on coronary vasomotor regulation in men with coronary heart desease. Circulation, 1999, 100, 1690-1696
21. English KM, Jones RD, Jones JH et al. - Testosterone acts as a coronary vasodilatator by a calcium channel antagonist action. J Endocrinol Invest, 2002, 25, 455-8
22. Herman Sm, Robinson JT, Mc credie RJ. - Androgens deprivation is asscociated with enhanced endothelium-dependent dilatation in adult men. Artherioscler Tromb Vasc Biol, 2002, 17, 2004-2009
23. Raitakari OT, Celemajer DS. - Flow-mediated dilatatation. Br J Clin Pharmacol, 2000, 50, 397-404.
24. Holm P, Andersen HL, Arroe G. - Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of endothelium and mononuclear-endothelial cell interaction. Circulation, 1998, 98, 2731-2737.
25. McGratj KCY, Sader MS, Nakla S et al. - Androgens up regulate VCAM-1 in a gender specific manner via NFKB-dependent pathway in human endothelial cells. Program of the 51st annual scientific meeting of the cardiac society of australia and New Zealand, Adelaide, Australia 2003 (abstract)
26. McCrohon JA, Death AK, Nakla S et al. - Androgen receptor expression is greater in macrophages from male than from female donnors. A sex difference with implications for atherogenesis. Circulation, 2000, 101, 224-226
27. Friedl R, Brunner M, Moeslinger T et al. - Testosterone inhibits expression of inductible nitric oxide synthase in murine macrophages. Life sci, 2000, 68, 417-429.
28. Ling S, Dai A, Williams MR. - Testosterone enhance apoptosis-related damage in human vascular endothelial cells. Endocrinology, 2002, 143, 1119-1125.
29. Fujimoto R, Morimoto I, Monta E. - Androgens receptors, 5alpha reductase activity and androgens-dependent proliferation of vacular smooth muscle cells. J steroid Biochem Mol Biol, 1994, 50, 169-174
30. The world health report 2002. Geneva, World Health Organisation.
31. Morris P, Pugh PJ, Hall J et al. - The relationship between smoking, statin therapy and testosterone in men with coronary artery disease. Endocrine Abstracts, 2002, 248
32. English K, Mandour O, Steeds RP, et al. - Men with coronary artery disease have a lower levels of testosterone than those with normal coronary angiograms. Eur Heart J, 2000, 21, 890-894
33. Feldman HA, Johannes CB, Araujo AB, et al. - Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2001, 153, 79-89.
34. Shapiro J, Christianaj J, Frishman W et al. - Testosterone and other anabolic steroids as cardiovascular drugs. Am J Ther, 1999, 6, 167-174.
35. Pugeat M, Moulin P, Cousin P et al. - Interrelations between sex-hormone binding globulin, plasma lipoproteins and cardiovascular risks. J Steroid Biochem Mol Biol, 1995, 53, 567-572
36. Loukorvaara M, Carson M, Adlercreutz H. - Regulation of production and secretion of sex-hormone binding globulin in HepG2 cell culture by hormones and growth factors. J clin Endocrinol Metab, 1995, 80, 160-164
37. Porsova-Dutoit, Sulcova J. - Do DHEA/DHEAS play a protective role in coronary heart disease? Physiol Res, 2000, 49, 43-56.
38. Khalil A, Lehoux JG, Wagner RJ et al. - Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by gammmaradiolys of ethanol-water mixture. Atherosclerosis, 1998, 136, 99-107
39. Jesse RL, Loesser K, Eich DM et al. - Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. Ann N Y Acad Sci, 1995, 774, 281-290
40. Beer NA, Jakubowicz DK, Madd DW et al. - Dehydroepiandrosterone reduces plasmaplasminogen activator inhibitor type 1 and tissue plasma activator antigen in men. Am J Med Sci, 1996, 311, 205-210